This guideline covers recognition, assessment and monitoring of faltering growth in infants and children. It includes a definition of growth thresholds for concern and identifying the risk factors for, and possible causes of, faltering growth. It also covers interventions, when to refer, service design, ...
This guideline covers increasing immunisation uptake among children and young people aged under 19 years in groups and settings where immunisation coverage is low. It aims to improve access to immunisation services and increase timely immunisation of children and young people. It also aims to ensure babi...
This guideline covers vitamin D supplement use. It aims to prevent vitamin D deficiency among specific population groups including infants and children aged under 4, pregnant and breastfeeding women, particularly teenagers and young women, people over 65, people who have low or no exposure to the sun and...
This guideline covers care and support for people with advanced (stage 4) breast cancer. It aims to help them and their healthcare professionals make shared decisions about tests and treatments to improve outcomes and quality of life. A table of NHS England interim treatment regimens gives possible alter...
This guideline covers the developmental follow-up of babies, children and young people under 18 years who were born preterm (before 37+0 weeks of pregnancy). It explains the risk of different developmental problems and disorders, and specifies what extra assessments and support children born preterm migh...
This guideline covers diagnosing and managing first or recurrent upper or lower urinary tract infections in infants, children and young people. It aims to achieve more consistent clinical practice, based on accurate diagnosis and effective management...
This guideline covers diagnosing and managing Parkinson's disease in people aged 18 and over. It aims to improve care from the time of diagnosis, including monitoring and managing symptoms, providing information and support, and palliative care....
Enfermedad de Parkinson/tratamiento farmacológico,
Enfermedad de Parkinson/diagnóstico,
Fármacos Neuroprotectores/uso terapéutico,
Vitamina E/uso terapéutico,
Agonistas de Dopamina/uso terapéutico,
Inhibidores de la Monoaminooxidasa/uso terapéutico,
Enfermedad de Parkinson/terapia,
Terapia Ocupacional,
Levodopa/uso terapéutico,
Carbidopa/uso terapéutico,
Cuidados Paliativos
This guideline covers diagnosing and managing constipation in children and young people up to 18. It provides strategies to support the early identification and timely, effective treatment of constipation which will help improve outcomes for patients. It does not cover constipation caused by a specific c...
East, J. E;
Atkin, W. S;
Bateman, A. C;
Clark, S. K;
Dolwani, S;
Ket, S. N;
Leedham, S. J;
Phull, P. S;
Rutter, M. D;
Shepherd, N. A;
Tomlinson, I;
Rees, C. J.
Serrated polyps have been recognised in the last decade as important premalignant lesions accounting for between 15% and 30% of colorectal cancers. There is therefore a clinical need for guidance on how to manage these lesions; however, the evidence base is limited. A working group was commission by the ...
Lanza, G;
Setacci, C;
Ricci, S;
Castelli, P;
Cremonesi, A;
Lanza, J;
Novali, C;
Pratesi, C;
Santalucia, P;
Speziale, F;
Zaninelli, A;
Gensini, G. F.
Although proof-based medicine has generated much valid evidence for the drawing up of guidelines and recommendations for best clinical practice in symptomatic and asymptomatic carotid stenosis, whether and when it is better to employ endarterectomy or stenting as the intervention of choice still remain m...
